War InjuryNCT03839017
Impact on Performance of the Use of a Digital Cognitive Aid in Simulated Crisis and Stress Situations
A study testing SIMMAXMARCHERYAN2 in people with War Injury, run by CEJKA Jean-Christophe at 1 site in France.
Trial summary
The previous investigators' studies (MAX, Lelaidier et al, BJA 2017, \& SIMMAXMARCHERYAN) clearly showed that the use of a digital cognitive aid in the hand of the leader significantly improves the management of anaesthesia and intensive care emergencies as well as basic combat casualty care. Read more about this study
- Who is it for?
- Ages 21 years and olderHealthy volunteers can take part
- Conditions the study is for
- War Injury
- What is being tested?
- SIMMAXMARCHERYAN2
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteFrance
- Study dates
- 29 Jan 2019to 21 Feb 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Military doctors and Nurses
- Under initial or continuous training of Combat Casualty Care 3rd level
- Agreed to use the cognitive aid
Who cannot join
- Doesn't agree to use the cognitive aid
Trial locations and contacts
1 site in 1 country.
About this study
The previous investigators' studies (MAX, Lelaidier et al, BJA 2017, \& SIMMAXMARCHERYAN) clearly showed that the use of a digital cognitive aid in the hand of the leader significantly improves the management of anaesthesia and intensive care emergencies as well as basic combat casualty care.
The present study exclusively deals with the advanced management of simulated combat casualties by military doctors and nurses using the same digital cognitive aid adapted for MARCHE RYAN algorithm.
Read the detailed description
The epidemiology of battlefield mortality highlights the need for safety and speed of care in an environment under very high stress. Indeed, it has been found that about 90% of those killed in action die before reaching the first hospital or care unit. Management algorithms such as ABCDE, SAFE MARCHE RYAN and local protocols are among the many doctrines to be applied by military health professionals when dealing with serious trauma in emergencies in different practice settings. During combat, their actions are carried out under enemy fire, in darkness, in extreme environments, for a significant number of victims and with limited means. As a result, on the battlefield, this multitude of choices and specific conditions of practice can make it difficult to apply the guidelines for the management of war-wounded in critical and stressful situations and can be a source of medical error. Health simulation is one of the main tools for training and preparation in a safe environment for unsafe situations ("never the first time on the patient"). A new decision-making and protocolization tool is available for health professionals: the MAX (Medical Assistant eXpert) cognitive aid, which has already proven its effectiveness in reducing the number of errors in the management of vital distress in anesthesia and in basic combat casualty care.
Materials and Methods:
Population studied: military doctors and nurses from the forces, both male and female, of varying ages and operational experience, planned to be deployed on External Operations (OPEX) or Short-term Mission (MCD), designated by the Val-de-Grâce School as learners for the " Survival Conditioning of the War Wounded " (MCSBG) continuing training course.
Study design (conduct): analytical, prospective, randomized, controlled, unblinded study conducted during the MCSBG training courses as part of the operational preparation of military doctors and nurses of the forces within the Center for Education and Simulation in Operational Medicine (CESimMO) in Toulon. The investigators had four pairs of learners work on one afternoon during each week-long training session. Each pair of learners completed two different scenarios of similar difficulty and complexity. Four blocks of scenarios were defined on which the pairs were able to work. The pairs were initially randomly assigned to two groups: Group 1 where the first scenario was performed with the MAX CA and Group 2 where the CA was used in the second scenario. Each group therefore performed a simulated scenario with and without MAX. The scenarios used either high-fidelity mannequins (SimMan 3G / ALS, Laerdal, Stavanger, Stavanger, Norway) or hybrid standardized patients (standardized subjects equipped with anatomical prostheses that allowed their management including technical procedures).
MAX CA Description: MAX is a digital AC, developed by J.C. CEJKA, and initially intended for the management of anesthesia and resuscitation emergencies. For the MARCHE RYAN protocol, each action was presented sequentially by the CA and had to be validated before the next one was displayed (READ and DO mode). It was possible to go back in order to review the validated actions and at the end of the procedure, the user had the possibility to make a final check of all his actions. The evaluation of the effectiveness of MAX was previously carried out at the Lyon center for teaching through health simulation (CLESS, UCBL1 - Claude Bernard University Lyon 1), but also during the training of Medicalization in hostile environments (MEDICHOS) and the continuing training in 2nd level combat rescue / casualty care (SC).
Use of the AC MAX in the study: Each participant disposed of a MAX application when dealing with war wounded in simulated situations. The presentation of the application and its handling was done on the first morning of each course, and a license for downloading and using the application was granted to each participant. The instructors were present to answer any questions about this CA. The anonymity of the study participants was ensured and their volunteering as well as the authorization to take pictures and use the videos collected at the beginning of each course.
Participants were requested to absolutely use the application for one of the two scenarios (randomized choice). The fact of being able to use MAX was communicated to them each time during the scenario briefing. More precisely, the one running the MARCHE RYAN algorithm had to use the MAX AC for a complete sequence, from the beginning of the scenario and follow MAX's prompts until the end of the protocol. The participants decided who in the pair will use MAX, however this person had to use both MAX+ and MAX- scenarios according to the MARCHE RYAN protocol. One of the instructors/facilitators who followed this process was to remind them of this requirement during the care of war wounded when necessary, and to impose the use of CA, if applicable.
Randomization by block allocation was performed using open source software R (randomizr library, R Foundation for Statistical Computing, Vienna, Austria, version 3.4.1), to have a homogeneous distribution of participants in Group 1 (MAX first) and Group 2 (MAX second), according to four blocks (1 block per scenario passage). The types of scenarios, the locations where the training took place and the distribution of trainers were the same for all MCSBG courses included in the study. The designation of the pairs was made on the first day of each course by the trainers in title of the CESimMO of Toulon, from the list of trainees participating.
The calculation of the number of subjects required was carried out a priori on the basis of data from the work of R. Lelaidier and M. Truchot studying the effect of MAX CA on technical and non-technical performance. In this work, the scenarios being of similar difficulty, investigators do not expect any significant effect from this factor, so the differences in means will be influenced by the use of MAX. The size of the expected effect was calculated from a mean difference of 13 points, and a standard deviation of sd=11, with n=8 groups (4 scenario blocks with or without MAX), which equates to a MAX CA effect size of 0.4 between the eight groups. The recruitment of 32 pairs will allow investigators to have a power of 0.88 with a first species risk of 0.05. In other words, a population of 32 pairs will allow investigators to show a minimum effect size of f=0.35, with a power of 0.8 and a first species risk of 0.05. There was no interim analysis planned for this study.
Data collection and analysis:
All performances were filmed (using GoPro Hero 4 cameras, San Mateo, California, USA) and anonymized. Each video recording of the MAX+ and MAX- scenarios was remotely rated by two independent evaluators (NP and PR), using the technical and non-technical performance rating grids. The scales used have already been published in international journals. If a difference of more than one point out of 10 was found between the two ratings, a third assessor (AP) would act as mediator.
A questionnaire (quiz) was also distributed to participants at the end of each course to find out how they felt about the influence of the use of the AC MAX on their performance.
- Conditions
- War Injury
- Being tested
- SIMMAXMARCHERYAN2
- Keywords
- Forward medicalization, Cognitive aid, Crisis situation, High-fidelity simulation, Performance
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SIMMAXMARCHERYAN2Device
Digital cognitive aid during the management of simulated war wounded.
| Study group | Role | What they receive |
|---|---|---|
| Digital cognitive aid | Experimental | The leader uses a digital cognitive aid designed as a smartphone app during advanced combat casualty care. Intervention: Device: SIMMAXMARCHERYAN2 Digital cognitive aid during the management of simulated war wounded. Receives: Device: SIMMAXMARCHERYAN2 |
| Without digital cognitive aid | Experimental | The leader practices advanced combat casualty care without the digital cognitive aid designed as a smartphone app. Intervention: Device: SIMMAXMARCHERYAN2 Without digital cognitive aid during the management of simulated war wounded. Receives: Device: SIMMAXMARCHERYAN2 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Technical Performance: percentage of actions and steps in the MARCHE RYAN protocol performed by each subject with or without the CA MAX
As compared to a Reference Task List including between 11 and 16 critical actions to be performed. This grid was used to rate technical performance in each scenario. Each action was recorded: 0 (action not performed), 1 (action performed at the wrong time, with the wrong dosage or inaccurately) or 2 (action performed correctly and at the right time). The individual scores were summed and transformed into a percentage of the maximum achievable score.
Statistical analysis and calculation of the number of pairs required:
The analysis of the effect of the use of MAX CA on learners' technical performance will be carried out using a 3-factor repeated-measure ANOVA: the use of MAX, the scenario, and whether the scenario is played first or second. A post-hoc analysis by the Bonferroni test will be carried out to compare the groups.
Measured: Time 0-30 minutes
Secondary outcomes (1)
Non technical skills performance measured using the TEAM scale, MAX+ vs MAX-
As measured by the TEAM scale score. Each of the 11 skills was rated between 0 and 4, and the overall performance between 1 and 10, for a maximum total of 54 points. Non-technical performance could therefore vary between 1 and 54.
Measured: Time 0-30 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Feb 2019
- Study start29 Jan 2019
- Primary completion21 Nov 2019
- Study completion21 Feb 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for War InjuryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- With or without the cognitive aid
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- CEJKA Jean-Christophe
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, CEJKA Jean-Christophe, Claude Bernard University
- Investigators
- Jean J Lehot, MD, PhD, Study director, Claude Bernard University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03839017
- Sponsor's protocol ID
- SIMMAXMARCHERYAN2
- Status last verified
- Jul 2020
- First submitted
- 7 Feb 2019
- Last updated
- 16 Jul 2020
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Paraschiv AP, Cejka JC, Lilot M, Aigle L, Lehot JJ, Balanca B. Impact of a Digital Cognitive Aid on the Performance of Military Healthcare Teams During Critical Care Management in a Warfront Injury Situation: A Simulation Randomized Controlled Study. Simul Healthc. 2022 Jun 1;17(3):163-169. doi: 10.1097/SIH.0000000000000623. Epub 2021 Dec 15.
PubMed 34934026
Study at a glance
From the registry record, last updated by the sponsor on 16 Jul 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact on Performance of the Use of a Digital Cognitive Aid in Simulated Crisis and Stress Situations
- ClinicalTrials.gov ID
- NCT03839017
- Acronym / sponsor ID
- SIMMAXMARCHERYAN2
- Conditions
- War Injury
- Keywords
- Forward medicalization, Cognitive aid, Crisis situation, High-fidelity simulation, Performance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- CEJKA Jean-ChristopheUniversity, hospital or other
- Study start
- 29 Jan 2019 (actual)
- Primary completion
- 21 Nov 2019 (actual)
- Study completion
- 21 Feb 2020 (actual)
- First posted
- 12 Feb 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The previous investigators' studies (MAX, Lelaidier et al, BJA 2017, \& SIMMAXMARCHERYAN) clearly showed that the use of a digital cognitive aid in the hand of the leader significantly improves the management of anaesthesia and intensive care emergencies as well as basic combat casualty care.
The present study exclusively deals with the advanced management of simulated combat casualties by military doctors and nurses using the same digital cognitive aid adapted for MARCHE RYAN algorithm.
Detailed description
The epidemiology of battlefield mortality highlights the need for safety and speed of care in an environment under very high stress. Indeed, it has been found that about 90% of those killed in action die before reaching the first hospital or care unit. Management algorithms such as ABCDE, SAFE MARCHE RYAN and local protocols are among the many doctrines to be applied by military health professionals when dealing with serious trauma in emergencies in different practice settings. During combat, their actions are carried out under enemy fire, in darkness, in extreme environments, for a significant number of victims and with limited means. As a result, on the battlefield, this multitude of choices and specific conditions of practice can make it difficult to apply the guidelines for the management of war-wounded in critical and stressful situations and can be a source of medical error. Health simulation is one of the main tools for training and preparation in a safe environment for unsafe situations ("never the first time on the patient"). A new decision-making and protocolization tool is available for health professionals: the MAX (Medical Assistant eXpert) cognitive aid, which has already proven its effectiveness in reducing the number of errors in the management of vital distress in anesthesia and in basic combat casualty care.
Materials and Methods:
Population studied: military doctors and nurses from the forces, both male and female, of varying ages and operational experience, planned to be deployed on External Operations (OPEX) or Short-term Mission (MCD), designated by the Val-de-Grâce School as learners for the " Survival Conditioning of the War Wounded " (MCSBG) continuing training course.
Study design (conduct): analytical, prospective, randomized, controlled, unblinded study conducted during the MCSBG training courses as part of the operational preparation of military doctors and nurses of the forces within the Center for Education and Simulation in Operational Medicine (CESimMO) in Toulon. The investigators had four pairs of learners work on one afternoon during each week-long training session. Each pair of learners completed two different scenarios of similar difficulty and complexity. Four blocks of scenarios were defined on which the pairs were able to work. The pairs were initially randomly assigned to two groups: Group 1 where the first scenario was performed with the MAX CA and Group 2 where the CA was used in the second scenario. Each group therefore performed a simulated scenario with and without MAX. The scenarios used either high-fidelity mannequins (SimMan 3G / ALS, Laerdal, Stavanger, Stavanger, Norway) or hybrid standardized patients (standardized subjects equipped with anatomical prostheses that allowed their management including technical procedures).
MAX CA Description: MAX is a digital AC, developed by J.C. CEJKA, and initially intended for the management of anesthesia and resuscitation emergencies. For the MARCHE RYAN protocol, each action was presented sequentially by the CA and had to be validated before the next one was displayed (READ and DO mode). It was possible to go back in order to review the validated actions and at the end of the procedure, the user had the possibility to make a final check of all his actions. The evaluation of the effectiveness of MAX was previously carried out at the Lyon center for teaching through health simulation (CLESS, UCBL1 - Claude Bernard University Lyon 1), but also during the training of Medicalization in hostile environments (MEDICHOS) and the continuing training in 2nd level combat rescue / casualty care (SC).
Use of the AC MAX in the study: Each participant disposed of a MAX application when dealing with war wounded in simulated situations. The presentation of the application and its handling was done on the first morning of each course, and a license for downloading and using the application was granted to each participant. The instructors were present to answer any questions about this CA. The anonymity of the study participants was ensured and their volunteering as well as the authorization to take pictures and use the videos collected at the beginning of each course.
Participants were requested to absolutely use the application for one of the two scenarios (randomized choice). The fact of being able to use MAX was communicated to them each time during the scenario briefing. More precisely, the one running the MARCHE RYAN algorithm had to use the MAX AC for a complete sequence, from the beginning of the scenario and follow MAX's prompts until the end of the protocol. The participants decided who in the pair will use MAX, however this person had to use both MAX+ and MAX- scenarios according to the MARCHE RYAN protocol. One of the instructors/facilitators who followed this process was to remind them of this requirement during the care of war wounded when necessary, and to impose the use of CA, if applicable.
Randomization by block allocation was performed using open source software R (randomizr library, R Foundation for Statistical Computing, Vienna, Austria, version 3.4.1), to have a homogeneous distribution of participants in Group 1 (MAX first) and Group 2 (MAX second), according to four blocks (1 block per scenario passage). The types of scenarios, the locations where the training took place and the distribution of trainers were the same for all MCSBG courses included in the study. The designation of the pairs was made on the first day of each course by the trainers in title of the CESimMO of Toulon, from the list of trainees participating.
The calculation of the number of subjects required was carried out a priori on the basis of data from the work of R. Lelaidier and M. Truchot studying the effect of MAX CA on technical and non-technical performance. In this work, the scenarios being of similar difficulty, investigators do not expect any significant effect from this factor, so the differences in means will be influenced by the use of MAX. The size of the expected effect was calculated from a mean difference of 13 points, and a standard deviation of sd=11, with n=8 groups (4 scenario blocks with or without MAX), which equates to a MAX CA effect size of 0.4 between the eight groups. The recruitment of 32 pairs will allow investigators to have a power of 0.88 with a first species risk of 0.05. In other words, a population of 32 pairs will allow investigators to show a minimum effect size of f=0.35, with a power of 0.8 and a first species risk of 0.05. There was no interim analysis planned for this study.
Data collection and analysis:
All performances were filmed (using GoPro Hero 4 cameras, San Mateo, California, USA) and anonymized. Each video recording of the MAX+ and MAX- scenarios was remotely rated by two independent evaluators (NP and PR), using the technical and non-technical performance rating grids. The scales used have already been published in international journals. If a difference of more than one point out of 10 was found between the two ratings, a third assessor (AP) would act as mediator.
A questionnaire (quiz) was also distributed to participants at the end of each course to find out how they felt about the influence of the use of the AC MAX on their performance.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- With or without the cognitive aid
| Arm | Type | Receives |
|---|---|---|
| Digital cognitive aid | Experimental | Device: SIMMAXMARCHERYAN2The leader uses a digital cognitive aid designed as a smartphone app during advanced combat casualty care. Intervention: Device: SIMMAXMARCHERYAN2 Digital cognitive aid during the management of simulated war wounded. |
| Without digital cognitive aid | Experimental | Device: SIMMAXMARCHERYAN2The leader practices advanced combat casualty care without the digital cognitive aid designed as a smartphone app. Intervention: Device: SIMMAXMARCHERYAN2 Without digital cognitive aid during the management of simulated war wounded. |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Military doctors and Nurses
- Under initial or continuous training of Combat Casualty Care 3rd level
- Agreed to use the cognitive aid
Key exclusion criteria (1 listed)
- Doesn't agree to use the cognitive aid
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SIMMAXMARCHERYAN2Digital cognitive aid during the management of simulated war wounded. | Device | Digital cognitive aid, Without digital cognitive aid |
Primary outcome
Technical Performance: percentage of actions and steps in the MARCHE RYAN protocol performed by each subject with or without the CA MAX
Time frame: Time 0-30 minutes
As compared to a Reference Task List including between 11 and 16 critical actions to be performed. This grid was used to rate technical performance in each scenario. Each action was recorded: 0 (action not performed), 1 (action performed at the wrong time, with the wrong dosage or inaccurately) or 2 (action performed correctly and at the right time). The individual scores were summed and transformed into a percentage of the maximum achievable score. Statistical analysis and calculation of the number of pairs required: The analysis of the effect of the use of MAX CA on learners' technical performance will be carried out using a 3-factor repeated-measure ANOVA: the use of MAX, the scenario, and whether the scenario is played first or second. A post-hoc analysis by the Bonferroni test will be carried out to compare the groups.
1 secondary outcome
Non technical skills performance measured using the TEAM scale, MAX+ vs MAX-
Time frame: Time 0-30 minutes
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jul 2020.
- Derived from this study: PubMed 34934026Paraschiv AP, Cejka JC, Lilot M, Aigle L, Lehot JJ, Balanca B. Impact of a Digital Cognitive Aid on the Performance of Military Healthcare Teams During Critical Care Management in a Warfront Injury Situation: A Simulation Randomized Controlled Study. Simul Healthc. 2022 Jun 1;17(3):163-169. doi: 10.1097/SIH.0000000000000623. Epub 2021 Dec 15.
- Précloux P, Wey P-F, Bérend M. et al. Opération " Pamir " : bilan et analyse de l'activité des postes médicaux de Rôle 1 à partir du Registre santé de l'avant pour l'année 2011. Médecine et Armées 2014, 42, 4: 299-308Link provided by the sponsor.
- Hoffmann et al. Épidémiologie des blessés de guerre français en Afghanistan : de la blessure à la réinsertion. Urgences 2015 - Congrès de la Société Française de Médecine d'Urgence, At Paris, Volume : Chapitre 83Link provided by the sponsor.
- Holcomb JB. Major scientific lessons learned in the trauma field over the last two decades. PLoS Med 2017, 14(7): e1002339Link provided by the sponsor.
- Holcomb JB, Stansbury LG, Champion HR et al. Understanding casualty care statistics. 2006, Repéré à PubMed.gov. DOI : 10.1097/01.ta.0000203581.75241.f1Link provided by the sponsor.
- Jones C, Bond C. 68W. Advanced Field Craft. Combat Medic Skills. 2010, AAOS (American Academy of Orthopaedic Surgeons). Jones and Bartlett Publishers USALink provided by the sponsor.
- École du Val-de-Grâce. Enseignement du Sauvetage au Combat. 2012Link provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Related trials for War Injury
RecruitingPhase 2
Preliminary Effectiveness of Hybrid Individual and Group MDMA-assisted Therapy for War-related PTSD
Post Traumatic Stress Disorder, MDMA ('Ecstasy')
Recruiting
Integrative Medicine for Hospital Workers Exposed to War
Anxiety
Active, not recruitingObservational study
Intergenerational Study of War-Affected Youth
Anxiety Disorders, Anxiety State
Not yet recruiting
Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness
Gulf War Syndrome
RecruitingPhase 1
Clinical Evaluation of Montelukast in Veterans With Gulf War Illness
Gulf War Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jean J Lehot, MD, PhD study director
Claude Bernard University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing SIMMAXMARCHERYAN2 in people with War Injury, run by CEJKA Jean-Christophe at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Technical Performance: percentage of actions and steps in the MARCHE RYAN protocol performed by each subject with or without the CA MAX (time frame: Time 0-30 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03839017, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2020.